BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 8164140)

  • 1. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
    Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
    J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical observation on pause-dependent long QT syndrome and torsade de pointes ventricular tachycardia].
    Song YC
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Dec; 20(6):349-51, 389. PubMed ID: 1307971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome.
    Noda T; Shimizu W; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S
    Eur Heart J; 2004 Dec; 25(23):2149-54. PubMed ID: 15571831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsades de pointes and long QT syndromes.
    Janeira LF
    Am Fam Physician; 1995 Oct; 52(5):1447-53. PubMed ID: 7572567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast and slow torsade de pointes--electrocardiographic characteristics.
    Kukla P; Słowiak-Lewińska T; Szczuka K; Plato A; Bromblik A; Hajduk B; Kluczewski M; Przewor M
    Kardiol Pol; 2004 Apr; 60(4):342-7. PubMed ID: 15226783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Torsade de pointes--a cause of Morgagni-Adam-Stokes attacks in patients with complete atrioventricular block].
    Antonelli D; Rozner E; Freedberg NA; Turgeman Y
    Harefuah; 2008 Mar; 147(3):204-6, 279. PubMed ID: 18488859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
    Kawabata M; Hirao K; Takeshi S; Sakurai K; Inagaki H; Hachiya H; Isobe M
    J Electrocardiol; 2008; 41(2):117-22. PubMed ID: 18328336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Torsades de pointes: analysis of 105 episodes].
    Maia IG; Sá R; Alves PA; Ribeiro JC; Fernandes PH; Guarçoni O; Bassan R; Dohmann HF
    Rev Port Cardiol; 1993 Feb; 12(2):163-8. PubMed ID: 8461156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Torsades de Pointes: analysis of 105 episodes].
    Maia IG; Sá R; Alves PA; Ribeiro JC; Fernandes PH; Guarçoni O; Bassan R; Dohmann HF
    Arq Bras Cardiol; 1991 Jun; 56(6):451-6. PubMed ID: 1823745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Torsades de pointes].
    Guize L; Iliou MC; Bayet G; Lavergne T; Le Heuzey JY
    Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):769-76. PubMed ID: 8267505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity.
    Yamaguchi M; Shimizu M; Ino H; Terai H; Uchiyama K; Oe K; Mabuchi T; Konno T; Kaneda T; Mabuchi H
    Clin Sci (Lond); 2003 Dec; 105(6):671-6. PubMed ID: 12857349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block.
    Cho MS; Nam GB; Kim YG; Hwang KW; Kim YR; Choi H; Kim SH; Rhee KS; Kim NJ; Kim JS; Kim J; Choi KJ; Kim YH
    Heart Rhythm; 2015 Mar; 12(3):498-505. PubMed ID: 25460857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired long QT syndrome: long-term electrocardiographic (Holter) recording of torsades de pointes ending in asystole: II.
    Raviña T; Gutierrez J; Raviña P
    Int J Cardiol; 2007 Mar; 116(2):272-5. PubMed ID: 16859777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.